About this journal

The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. Cancer immunotherapies are coming of age and have the potential to produce long-lasting remission, often with fewer side effects and reduced drug resistance compared with conventional therapies. Recently the FDA has approved immunotherapies for melanoma and lung cancer, and clinical trials are yielding positive results for a range of cancer types, reflecting the promising new role for immunotherapy in cancer treatment. Immunotherapies are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV and hepatitis.

Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

Articles published in Immunotherapy include key areas such as:

• Cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies and cytokines
• Combined chemo/radio immunotherapy in cancer treatment
• Biomarkers for personalized cancer immunotherapy
• Allergen immunotherapy, including sublingual, subcutaneous and oral immunotherapy
• Restorative immunotherapy for HIV and other immunocompromised patients
• Suppressive immunotherapy for autoimmunity diseases and transplantation
• Basic science of immunotherapeutic approaches
• Drug–immune system interactions
• Drug delivery systems, drug combinations and drug–drug interactions
• Summaries evaluating newly approved immunotherapeutic agents
• Newly identified immune targets of drugs
• Results of recent findings and clinical trials relevant to the field of immunotherapy
• Post marketing research, including adverse events, drug safety, pharmacoeconomics, cost–benefit issues, real-world evidence and outcomes research

Immunotherapy delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.

Senior Editors

Tsang K, Precision Biologics, Inc, National Cancer Institute, USA
Kawakami Y, Keio University School of Medicine, Tokyo, Japan
Marincola FM, Sidra Medical and Research Centre, Doha, Qatar
Wraith DC, University of Birmingham, UK

Associate Editors

Apostolopoulos V, Victoria University, Australia
Fung JJ, Cleveland Clinic Foundation, OH, USA
Puri RK, Food and Drug Administration, MD, USA
Sato N, Sapporo Medical University School of Medicine, Japan

Editorial Board

Ablin RJ, University of Arizona College of Medicine, AZ, USA
Adams S, NYU Cancer Institute, NY, USA
Alexander S, Children’s Hospital at Westmead, Australia
Bayry J, INSERM, Paris, France
Bohle B, Medical University of Vienna, Austria
Brander C, Fundació irsiCaixa, Hospital Universitari Germans Trias i Pujol, Spain
Buonaguro L, Istituto Nazionale Tumori ‘Fond. G. Pascale’, Italy
Dalgleish A, St George’s University of London, UK
Darcy PK, Peter MacCallum Cancer Centre, Australia
Griffith TS, University of Minnesota, MN, USA
Janda KD, The Scripps Research Institute, CA, USA
Jackson AM, University of Nottingham, UK
Kabelitz D, University of Kiel, Germany
Kaveri SV, INSERM, Paris, France
Kirkwood JM, University of Pittsburgh, PA, USA
Mazda O, Kyoto Prefectural University of Medicine, Japan
Platt JL, University of Michigan, MI, USA
Sasada T, Kurume University School of Medicine, Japan
Shapira MY, Hadassah-Hebrew University Medical Center, Israel
Shariat SF, Medical University Vienna, Austria
Stauss HJ, University College London, UK
Trzonkowski P, Medical University of Gdansk, Poland
Yamamura T, National Institute of Neurosicences, Tokyo, Japan
Zamvil SS, University of California San Francisco, CA, USA